Published in Top Spinal Cord Inj Rehabil on January 01, 2012
An expert consensus on the evaluation and treatment of acute thoracolumbar spine and spinal cord injury in China. Neural Regen Res (2013) 1.11
Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis (2010) 6.70
Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers. J Spinal Cord Med (2006) 1.94
Catheter-associated urinary tract infections. Infect Dis Clin North Am (1997) 1.89
Effect of bladder management on urological complications in spinal cord injured patients. J Urol (2000) 1.88
Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol (2000) 1.78
Mortality, morbidity, and psychosocial outcomes of persons spinal cord injured more than 20 years ago. Paraplegia (1992) 1.61
Urinary tract infection in persons with spinal cord injury. Arch Phys Med Rehabil (1995) 1.51
The prevention and management of urinary tract infections among people with spinal cord injuries. National Institute on Disability and Rehabilitation Research Consensus Statement. January 27-29, 1992. J Am Paraplegia Soc (1992) 1.41
Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med (2002) 1.34
Management of urinary tract infection in patients with spinal cord injuries. Clin Microbiol Infect (2003) 1.33
Differences in urinary tract infections in male and female spinal cord injury patients on intermittent catheterization. Paraplegia (1995) 1.10
Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole. Am J Med (1993) 1.01
A swing to intermittent clean self-catheterisation as a preferred mode of management of the neuropathic bladder for the dextrous spinal cord patient. Paraplegia (1988) 0.98
Epidemiology and risk factors for urinary tract infection following spinal cord injury. Arch Phys Med Rehabil (1993) 0.98
Clean, intermittent self-catheterization in the treatment of urinary tract disease. 1972. J Urol (2002) 0.94
Pharmacologic therapy for the neurogenic bladder. Urol Clin North Am (2010) 0.92
Review of neurologic diseases for the urologist. Urol Clin North Am (2010) 0.89
Urological care of the spinal cord-injured patient. J Wound Ostomy Continence Nurs (2008) 0.88
The epidemiology of urinary tract infection and the concept of significant bacteriuria. Infection (1990) 0.85
Efficacy and safety of clean intermittent catheterization in adults. Eur Urol (1991) 0.80
Bladder instillations of trisdine compared with catheter introducer for reduction of bacteriuria during intermittent catheterisation of patients with acute spinal cord trauma. Br J Urol (1991) 0.80
Methenamine mandelate with acidification: an effective urinary antiseptic in patients with neurogenic bladder. Mayo Clin Proc (1984) 0.79
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med (2003) 11.25
Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol (2011) 5.01
A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. J Urol (2005) 1.54
Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA (2011) 1.46
Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis. J Urol (2007) 1.03
The management of interstitial cystitis: an update. Nat Clin Pract Urol (2006) 0.94
Recruitment for a clinical trial of drug treatment for benign prostatic hyperplasia. Urology (2002) 0.93
Recruitment of participants to a clinical trial of botanical therapy for benign prostatic hyperplasia. J Altern Complement Med (2011) 0.88
Suprapubic cystostomy for neurogenic bladder using Lowsley retractor method: a procedure revisited. Urology (2011) 0.88
Doxazosin-induced up-regulation of alpha 1A-adrenoceptor mRNA in the rat lower urinary tract. Can J Physiol Pharmacol (2004) 0.83
Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo. J Urol (2007) 0.83
Developmental changes in the functional, biochemical and molecular properties of rat bladder endothelin receptors. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.82
Age related changes in the functional, biochemical and molecular properties of alpha1-adrenoceptors in the rat genitourinary tract. J Urol (2006) 0.81
Early termination of a trial of mycophenolate mofetil for treatment of interstitial cystitis/painful bladder syndrome: lessons learned. J Urol (2011) 0.79
Renal tract ultrasonography for routine surveillance in spinal cord injury patients. Top Spinal Cord Inj Rehabil (2013) 0.78
Molecular classification of doxazosin-induced alterations in the rat prostate using gene expression profiling. Life Sci (2005) 0.78
Quantification of endothelins, their receptors, and endothelin-converting enzyme mRNAs in rat genitourinary tract using real-time RT-PCR. J Pharmacol Toxicol Methods (2003) 0.78
Doxazosin treatment causes differential alterations of alpha 1-adrenoceptor subtypes in the rat kidney, heart and aorta. Life Sci (2004) 0.78
Use of vanilloids in urologic disorders. Prog Drug Res (2014) 0.77